Durable and controlled depletion of neutrophils in mice.
Journal article

Durable and controlled depletion of neutrophils in mice.

  • Boivin G Swiss Institute for Experimental Cancer Research, School of Life Sciences, Ecole Polytechnique Fédérale de Lausanne, CH-1015, Lausanne, Switzerland.
  • Faget J Swiss Institute for Experimental Cancer Research, School of Life Sciences, Ecole Polytechnique Fédérale de Lausanne, CH-1015, Lausanne, Switzerland.
  • Ancey PB Swiss Institute for Experimental Cancer Research, School of Life Sciences, Ecole Polytechnique Fédérale de Lausanne, CH-1015, Lausanne, Switzerland.
  • Gkasti A Swiss Institute for Experimental Cancer Research, School of Life Sciences, Ecole Polytechnique Fédérale de Lausanne, CH-1015, Lausanne, Switzerland.
  • Mussard J University of Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, Cancer Research Center of Lyon, 69373, Lyon, France.
  • Engblom C Center for Systems Biology, Massachusetts General Hospital Research Institute and Harvard Medical School, Boston, MA, 02114, USA.
  • Pfirschke C Center for Systems Biology, Massachusetts General Hospital Research Institute and Harvard Medical School, Boston, MA, 02114, USA.
  • Contat C Swiss Institute for Experimental Cancer Research, School of Life Sciences, Ecole Polytechnique Fédérale de Lausanne, CH-1015, Lausanne, Switzerland.
  • Pascual J Swiss Institute for Experimental Cancer Research, School of Life Sciences, Ecole Polytechnique Fédérale de Lausanne, CH-1015, Lausanne, Switzerland.
  • Vazquez J Swiss Institute for Experimental Cancer Research, School of Life Sciences, Ecole Polytechnique Fédérale de Lausanne, CH-1015, Lausanne, Switzerland.
  • Bendriss-Vermare N University of Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, Cancer Research Center of Lyon, 69373, Lyon, France.
  • Caux C University of Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, Cancer Research Center of Lyon, 69373, Lyon, France.
  • Vozenin MC Laboratory of Radiation Oncology, Department of Radiation Oncology, Department of Oncology, CHUV, Lausanne University Hospital and University of Lausanne, CH-1011, Lausanne, Switzerland.
  • Pittet MJ Center for Systems Biology, Massachusetts General Hospital Research Institute and Harvard Medical School, Boston, MA, 02114, USA.
  • Gunzer M Institute for Experimental Immunology and Imaging, University Hospital, University Duisburg-Essen, Essen, Germany.
  • Meylan E Swiss Institute for Experimental Cancer Research, School of Life Sciences, Ecole Polytechnique Fédérale de Lausanne, CH-1015, Lausanne, Switzerland. etienne.meylan@epfl.ch.
Show more…
  • 2020-06-04
Published in:
  • Nature communications. - 2020
English Neutrophils are an essential part of the innate immune system. To study their importance, experimental studies often aim to deplete these cells, generally by injecting anti-Ly6G or anti-Gr1 antibodies. However, these approaches are only partially effective, transient or lack specificity. Here we report that neutrophils remaining after anti-Ly6G treatment are newly derived from the bone marrow, instead of depletion escapees. Mechanistically, newly generated, circulating neutrophils have lower Ly6G membrane expression, and consequently reduced targets for anti-Ly6G-mediated depletion. To overcome this limitation, we develop a double antibody-based depletion strategy that enhances neutrophil elimination by anti-Ly6G treatment. This approach achieves specific, durable and controlled reduction of neutrophils in vivo, and may be suitable for studying neutrophil function in experimental models.
Language
  • English
Open access status
gold
Identifiers
Persistent URL
https://sonar.ch/global/documents/278275
Statistics

Document views: 41 File downloads: